| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.05B | 100.97B | 101.36B | 97.40B | 81.60B | 63.57B |
| Gross Profit | 14.70B | 14.37B | 14.11B | 13.84B | 12.17B | 9.78B |
| EBITDA | 4.57B | 4.40B | 4.47B | 4.78B | 3.69B | 2.40B |
| Net Income | 2.42B | 2.66B | 2.50B | 2.74B | 2.09B | 1.34B |
Balance Sheet | ||||||
| Total Assets | 60.61B | 63.69B | 65.13B | 64.08B | 59.15B | 49.32B |
| Cash, Cash Equivalents and Short-Term Investments | 9.46B | 8.97B | 8.23B | 6.49B | 6.05B | 8.79B |
| Total Debt | 1.33B | 1.50B | 1.73B | 5.09B | 2.87B | 1.70B |
| Total Liabilities | 19.77B | 22.84B | 26.05B | 28.46B | 25.97B | 19.38B |
| Stockholders Equity | 40.81B | 40.82B | 39.06B | 35.59B | 33.17B | 29.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.72B | 5.97B | -898.00M | -1.18B | 2.78B |
| Operating Cash Flow | 0.00 | 1.82B | 6.08B | -716.00M | -890.00M | 3.14B |
| Investing Cash Flow | 0.00 | -95.00M | -84.00M | -191.00M | -3.81B | -981.00M |
| Financing Cash Flow | 0.00 | -1.31B | -4.42B | 1.20B | 2.05B | -660.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥61.27B | 10.45 | ― | 2.87% | -14.07% | 17.85% | |
75 Outperform | ¥37.13B | 9.78 | ― | 3.02% | 13.06% | 7.85% | |
70 Outperform | ¥71.10B | 15.74 | 5.37% | 3.41% | -4.59% | 25.08% | |
66 Neutral | ¥703.51B | 30.45 | ― | 0.79% | 3.53% | -18.43% | |
64 Neutral | ¥461.95B | 14.59 | ― | 2.87% | 12.90% | -40.53% | |
62 Neutral | ¥98.14B | 7.90 | ― | 2.41% | 50.28% | 79.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |